Leo pharma finalizes acquisition of key assets from timber pharmaceuticals

Ballerup, denmark--(business wire)--leo pharma today announced that it has finalized the acquisition of the strategic asset tmb-001 as well as certain other assets from timber pharmaceuticals following its chapter 11 bankruptcy filing. the tmb-001 project aims to develop a topical treatment for multiple moderate to severe subtypes of congenital ichthyosis – a skin disease with significant unmet need and no approved prescription therapies available. the tmb-001 project continues as planned and w.
TMBR Ratings Summary
TMBR Quant Ranking